NYSEAMERICAN:PTN Palatin Technologies (PTN) Stock Price, News & Analysis $0.88 -0.01 (-1.12%) (As of 10/1/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest About Palatin Technologies Stock (NYSEAMERICAN:PTN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Palatin Technologies alerts:Sign Up Key Stats Today's Range$0.84▼$0.9650-Day Range N/A52-Week Range$0.68▼$5.65Volume806,283 shsAverage Volume371,384 shsMarket Capitalization$17.05 millionP/E RatioN/ADividend YieldN/APrice Target$17.00Consensus RatingBuy Company OverviewPalatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.Read More… Get Ready for Next Week’s Elon Musk Shock (Ad)I believe Elon Musk is about to shock the world again next week… When he’s set to unveil his new AI product. I’m hosting a special online strategy session to help you prepare on Monday at 10am ET.Click here to see the details and save your seat. Palatin Technologies Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks39th Percentile Overall ScorePTN MarketRank™: Palatin Technologies scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingPalatin Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragePalatin Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Palatin Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Palatin Technologies is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Palatin Technologies is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPalatin Technologies has a P/B Ratio of 88.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.09% of the float of Palatin Technologies has been sold short.Short Interest Ratio / Days to CoverPalatin Technologies has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in Palatin Technologies has recently decreased by 3.65%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPalatin Technologies does not currently pay a dividend.Dividend GrowthPalatin Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.09% of the float of Palatin Technologies has been sold short.Short Interest Ratio / Days to CoverPalatin Technologies has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in Palatin Technologies has recently decreased by 3.65%, indicating that investor sentiment is improving. News and Social Media2.5 / 5News Sentiment0.55 News SentimentPalatin Technologies has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Palatin Technologies this week, compared to 2 articles on an average week.Search Interest5 people have searched for PTN on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Palatin Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Palatin Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,298.00 in company stock.Percentage Held by InsidersOnly 7.10% of the stock of Palatin Technologies is held by insiders.Percentage Held by InstitutionsOnly 11.50% of the stock of Palatin Technologies is held by institutions.Read more about Palatin Technologies' insider trading history. Receive PTN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Palatin Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address PTN Stock News HeadlinesBuy Rating Affirmed: Palatin Technologies’ Strong Earnings and Promising Pipeline Signal Growth OpportunitiesOctober 1 at 8:55 PM | markets.businessinsider.comPalatin Technologies (NYSEAMERICAN:PTN) Earns Buy Rating from HC WainwrightOctober 1 at 12:29 PM | americanbankingnews.comGet Ready for Next Week’s Elon Musk Shock I believe Elon Musk is about to shock the world again next week… When he’s set to unveil his new AI product. I’m hosting a special online strategy session to help you prepare on Monday at 10am ET.October 2, 2024 | InvestorPlace (Ad)Palatin Technologies Inc. Q4 Loss NarrowsOctober 1 at 8:36 AM | markets.businessinsider.comPalatin Reports Fourth Quarter and Fiscal Year Ended 2024 Financial Results, Provides Update on Clinical Programs, Strategic Priorities, and Anticipated MilestonesOctober 1 at 7:30 AM | prnewswire.comPalatin Technologies Inc (PTN) Q4 2024 Earnings Report Preview: What To ExpectSeptember 30 at 12:41 PM | finance.yahoo.comPalatin Techs (AMEX:PTN) Stock, Short Interest ReportSeptember 27, 2024 | benzinga.comPalatin to Report Fourth Quarter and Fiscal Year End 2024 ResultsSeptember 26, 2024 | prnewswire.comSee More Headlines PTN Stock Analysis - Frequently Asked Questions How have PTN shares performed this year? Palatin Technologies' stock was trading at $4.00 at the beginning of the year. Since then, PTN shares have decreased by 78.0% and is now trading at $0.88. View the best growth stocks for 2024 here. How were Palatin Technologies' earnings last quarter? Palatin Technologies, Inc. (NYSEAMERICAN:PTN) released its quarterly earnings data on Monday, September, 30th. The biopharmaceutical company reported ($0.49) earnings per share for the quarter. The biopharmaceutical company earned $0.35 million during the quarter. When did Palatin Technologies' stock split? Shares of Palatin Technologies reverse split on Wednesday, August 31st 2022. The 1-25 reverse split was announced on Wednesday, August 31st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 31st 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of Palatin Technologies? Shares of PTN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Palatin Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Palatin Technologies investors own include Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), Trevena (TRVN), Alliqua Biomedical (ALQA), Catalyst Pharmaceuticals (CPRX) and AVEO Pharmaceuticals (AVEO). Company Calendar Last Earnings5/15/2024Today10/01/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNYSEAMERICAN:PTN Previous SymbolNYSE:PTN CUSIPN/A CIK911216 Webwww.palatin.com Phone(609) 495-2200Fax609-495-2202Employees30Year FoundedN/APrice Target and Rating Average Stock Price Target$17.00 High Stock Price Target$17.00 Low Stock Price Target$17.00 Potential Upside/Downside+1,831.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($2.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-27,540,000.00 Net Margins-445.12% Pretax Margin-601.37% Return on EquityN/A Return on Assets-242.91% Debt Debt-to-Equity RatioN/A Current Ratio1.20 Quick Ratio1.20 Sales & Book Value Annual Sales$4.85 million Price / Sales3.51 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book88.00Miscellaneous Outstanding Shares19,370,000Free Float14,991,000Market Cap$17.05 million OptionableNot Optionable Beta1.01 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report This page (NYSEAMERICAN:PTN) was last updated on 10/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredThey laughed when he picked Nvidia in 2016…Everyone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredFor Elon, I fear the worst is yet to come…Early last year I predicted that there would be a war on Elon Musk. This hateful rhetoric has led to two s...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palatin Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palatin Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.